Innovative approach helps new mothers get hepatitis C treatment

Hepatitis C, a bloodborne virus that damages the liver, can cause cirrhosis, liver cancer, liver failure and death if left untreated. Despite the availability of highly effective treatments, the prevalence of hepatitis C infection remains high, particularly among women of childbearing age, who account for more than one-fifth of chronic hepatitis C infections globally. Within this group, new mothers are especially vulnerable because treatment has traditionally required outpatient follow-up appointments during the challenging postpartum period.